GLP-1 Weight Loss Injections Memphis Semaglutide & Tirzepatide

Weight Loss Injections

Physician-led GLP-1 injections in Memphis, including semaglutide and tirzepatide, delivered by our full team with a physician on location, plus labs, dose monitoring, and coaching.

What Are GLP-1 Weight Loss Injections?

GLP-1 weight loss injections are once-weekly prescription medicines that copy a natural gut hormone called GLP-1. They tell your brain you're full, slow how fast your stomach empties, and steady your blood sugar. Most people eat less without fighting constant hunger.

The two most prescribed are semaglutide and tirzepatide. Semaglutide is sold as Wegovy for weight loss and Ozempic for type 2 diabetes. Tirzepatide is sold as Zepbound for weight loss and Mounjaro for diabetes. Many people who search for Ozempic in Memphis are really looking for Wegovy, the same medicine approved for weight loss.

The clinical evidence is strong, and we read it carefully. In clinical trials, people on semaglutide lost about 15% of their body weight in 68 weeks (STEP 1, New England Journal of Medicine). People on the highest dose of tirzepatide lost about 21% in 72 weeks (SURMOUNT-1).

At Germantown Aesthetics, Gregory Laurence MD prescribes and monitors GLP-1 injections as part of our medical weight loss program in Memphis. Our full team works with a physician on location at every step. Patients come to us from Memphis, Germantown, Collierville, Cordova, and nearby areas.

Semaglutide vs. Tirzepatide: Which Is Right for You?

Comparing semaglutide and tirzepatide in Memphis? Both work well. The better choice depends on your health history, how your body handles the medicine, and what your insurance covers.

Semaglutide and tirzepatide at a glance

Semaglutide

Wegovy and Ozempic

13.7%

average weight loss at 72 weeks in the head-to-head trial

Weight loss brand
Wegovy
Diabetes brand
Ozempic
How it works
Acts on one appetite hormone (GLP-1)
How it's taken
Weekly injection, or the daily Wegovy pill

Tirzepatide

Zepbound and Mounjaro

20.2%

average weight loss at 72 weeks in the head-to-head trial

Weight loss brand
Zepbound
Diabetes brand
Mounjaro
How it works
Acts on two appetite hormones (GLP-1 and GIP)
How it's taken
Weekly injection; there is no pill

In the only head-to-head trial so far, tirzepatide produced more weight loss than semaglutide (SURMOUNT-5, 2025). That doesn't make it right for everyone.

Some people do very well on semaglutide or tolerate it better. Others have insurance coverage for only one. Dr. Laurence reviews your labs, medicines, and goals before recommending either, and sometimes the honest recommendation is neither.

Who Qualifies for GLP-1 Weight Loss Treatment?

You may qualify for GLP-1 treatment if you're an adult with:

  • a BMI of 30 or higher (obesity), or
  • a BMI of 27 or higher plus a weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea.

These are the FDA criteria for Wegovy and Zepbound. You don't need to have tried every diet first. The medicines work best alongside changes in eating and activity.

GLP-1 medicines aren't right for everyone, and for some patients a hormone evaluation is the better place to start. They aren't used during pregnancy or breastfeeding, or by anyone with a personal or family history of medullary thyroid cancer or MEN 2 (multiple endocrine neoplasia type 2).

A history of pancreatitis, gallbladder disease, or diabetic eye disease needs a careful conversation first. That's why every patient starts with a physician exam and lab work, so the decision rests on your biology rather than a trend.

Woman looking down at a bathroom scale in a gym
Starting with an honest baseline

GLP-1 Side Effects and Safety

Every effective medicine carries side effects, and we would rather you hear about them from us before you start.

The most common side effects are nausea, diarrhea, constipation, vomiting, and stomach upset. They're most likely in the first weeks and after each dose increase. Smaller meals, stopping before you're full, and raising the dose slowly all help. If side effects get in the way, your physician and our team adjust the plan with you rather than leave you to push through.

Serious risks are less common. They include pancreatitis, gallbladder problems, and low blood sugar when combined with some diabetes medicines. GLP-1s also carry a boxed warning about thyroid C-cell tumors seen in animal studies.

In November 2026, the FDA added a warning to all GLP-1 medicines about NAION, a rare optic nerve condition that can cause sudden, painless vision loss in one eye. If you notice sudden vision changes, blind spots, or blurring, call us and get eye care right away.

Our on-site physician supervision is intended to minimize these risks as part of helping you flourish. You get screening before you start, regular check-ins during treatment, and a doctor who knows your history when questions come up.

Man measuring his waist with a tape measure while holding pills in his other hand
Tracking more than the scale

Brand-Name, Compounded, and Pill Options

Brand-name medicines such as Wegovy, Zepbound, Ozempic, and Mounjaro are FDA-approved. That means the FDA has reviewed their safety, effectiveness, and manufacturing quality.

Compounded semaglutide and tirzepatide are mixed by pharmacies and aren't FDA-approved. They became common during the drug shortages of 2022 to 2024. The FDA has since declared those shortages over and moved to limit large-scale compounding.

If you're comparing compounded semaglutide in Memphis, ask where it's made, how it's tested, and whether it's the same form of the drug used in clinical trials.

GLP-1 pills are an option if you'd rather not inject. The FDA approved the Wegovy pill (oral semaglutide) in December 2025 and Foundayo (orforglipron) in April 2026. There is no tirzepatide pill.

At your consultation, we'll talk through which option fits your health, goals, and budget, and which one you can sustain over the long term.

Your GLP-1 Treatment Journey in Memphis

What to expect, step by step

Most people notice less hunger within the first few weeks. Weight loss builds steadily as the dose increases over several months.

Consultation and Labs

Dr. Laurence reviews your health history, current medications, and goals, and orders lab work. Together you decide whether a GLP-1 medication makes sense and which one to start with.

Starting Low

You begin with the lowest dose. It's raised gradually, usually every four weeks, so your body can adjust and side effects stay manageable. We show you how to give your weekly shot at home.

Regular Check-Ins

We track your progress, side effects, and labs, and adjust your dose. Your weight loss coach works alongside Physician, Dr. Laurence, on location to help you eat enough protein and stay active, which protects muscle while you lose fat

Keeping It Off

Studies show most people regain weight after stopping a GLP-1, so from day one we build for longer-lasting results rather than a quick number on the scale. That may mean a maintenance dose, a gradual taper, or a plan built on the habits you've formed.

More Than a Prescription

GLP-1 injections at Germantown Aesthetics are part of our physician-supervised medical weight loss program. It includes lab testing, custom meal planning, and a dedicated weight loss coach.

Weight is often only part of the picture. When hormones are shaping how you look and feel, our hormone replacement therapy may be the better first step or can be coordinated with your plan.

After major weight loss, some patients choose liposuction or a CombiTuck tummy tuck to address loose skin or stubborn areas. Dr. Laurence looks for balance from one area of the body to another and can talk you through those options when the time is right.

Smiling woman holding out the waistband of pants that are now too loose
Results you can feel

GLP-1 Weight Loss Questions & Answers

Answers to the questions Memphis patients ask most about semaglutide, tirzepatide, and weight loss injections.

GLP-1 weight loss injections are once-weekly prescription medicines, such as semaglutide (Wegovy) and tirzepatide (Zepbound). They copy a natural gut hormone that reduces appetite, slows digestion, and steadies blood sugar. Most people eat less without constant hunger. Paired with healthy eating and activity, that leads to steady weight loss.

Usually, yes. When people search for weight loss shots in Memphis, they usually mean GLP-1 injections such as semaglutide (Wegovy) or tirzepatide (Zepbound). Some clinics also sell vitamin B12 or "lipotropic" shots. Those aren't GLP-1 medicines and don't have the same evidence for weight loss.

Yes. Semaglutide is the active ingredient in both. Wegovy is the brand approved for weight loss, and Ozempic is the brand approved for type 2 diabetes. The Wegovy pill is an oral form of semaglutide approved for weight loss in December 2025.

Yes. Tirzepatide is the active ingredient in both. Zepbound is approved for weight loss and obstructive sleep apnea, and Mounjaro is approved for type 2 diabetes. Tirzepatide acts on two hormones, GLP-1 and GIP.

Tirzepatide produced more weight loss in the only head-to-head trial. In SURMOUNT-5, people on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% on semaglutide. The better choice for you depends on your health history, how well you tolerate the medicine, and your insurance. Dr. Laurence reviews all three with you.

Most people in clinical trials lost 15% to 21% of their body weight. People on semaglutide lost about 15% over 68 weeks. People on the highest dose of tirzepatide lost about 21% over 72 weeks. Results vary from person to person. They're strongest when the medicine is paired with better eating, activity, and coaching.

Cost depends on the medication, the dose, and whether your insurance covers it. Some plans cover GLP-1 medications for weight loss. If you're paying without insurance, the makers of Wegovy and Zepbound offer self-pay programs. At your consultation, we review your coverage and self-pay options so you know the cost before you start. Call (901) 624-5605 with questions.

The most common side effects are nausea, diarrhea, constipation, vomiting, and stomach upset. They're most likely in the first weeks and after a dose increase. Starting low, raising the dose slowly, and eating smaller meals help. Serious risks are less common. They include pancreatitis, gallbladder problems, and low blood sugar when combined with some diabetes medicines.

Rarely. In November 2026, the FDA required all GLP-1 medications to carry a warning about NAION, a rare optic nerve condition that can cause sudden, painless vision loss in one eye. The FDA's review found it uncommon, but anyone who notices sudden vision changes, blind spots, or blurring should contact their doctor and seek eye care right away.

GLP-1 medicines aren't used during pregnancy or breastfeeding. They also aren't used by anyone with a personal or family history of medullary thyroid cancer or MEN 2 (multiple endocrine neoplasia type 2). People with a history of pancreatitis, gallbladder disease, or diabetic eye disease need a careful evaluation first. Dr. Laurence screens every patient with a health history and lab work.

Most people regain some weight after stopping. In a follow-up to the STEP 1 trial, participants regained about two-thirds of the weight they had lost within a year of stopping semaglutide. That's why we plan for the long term from the start, whether that means a maintenance dose, a gradual taper, or a plan built on the habits you've formed.

Compounded semaglutide and tirzepatide aren't FDA-approved. That means the FDA hasn't reviewed them for safety, effectiveness, or quality. They became common during drug shortages that the FDA has since declared over. The FDA has also moved to limit large-scale compounding of both drugs. We'll explain how brand-name and other options compare at your consultation.

Yes. The FDA approved the Wegovy pill, a daily oral form of semaglutide, in December 2025, and Foundayo (orforglipron), a daily GLP-1 pill from Eli Lilly, in April 2026. There is no FDA-approved tirzepatide pill. Pills and injections each have trade-offs, which we can talk through at your visit.

Call Germantown Aesthetics at (901) 624-5605 or book a consultation online. Our office is at 7465 Poplar Avenue, Suite 102, in Germantown, minutes from Memphis, Collierville, and Cordova. Whether you're asking about Wegovy, Zepbound, or the Wegovy pill, your first visit includes a health review and lab work so Dr. Laurence can recommend the right medication and dose.

Find Out If GLP-1 Treatment Is Right for You

Meet with Dr. Laurence in Germantown, minutes from Memphis, for a medical evaluation and a plan built around your health.

Germantown Aesthetics' Reviews

Rated 4.8 out of 5 stars in 169 Google reviews

See all our Google reviews

Ready to "Stop Fighting Hunger and Start Losing Weight?"

Semaglutide and tirzepatide have changed what's possible for people who've struggled with their weight for years. With a physician on location, lab monitoring, and a full coaching team at Germantown Aesthetics, you get the medication, the support, and a plan built for longer-lasting results.

Schedule your GLP-1 weight loss consultation in Memphis today!